Biotech company Sarepta Therapeutics (NASDAQ:SRPT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, ...

We recently published a list of Was Jim Cramer Right About These 11 Stocks? In this article, we are going to take a look at ...

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the July 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading this week, for the June 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

[1] This development boded well for its stock. However, if we look at a somewhat longer term, SRPT stock has seen little change, moving slightly from levels of $170 in early January 2021 to around ...

Sarepta Therapeutics (SRPT) stock is gaining on Wednesday as Oppenheimer raised its price target on the stock in anticipation of a positive outcome for its eteplirsen drug. Sarepta Therapeutics ...

Get the annual and quarterly balance sheet of Sarepta Therapeutics, Inc. (SRPT) including details of assets, liabilities and shareholders' equity.

SRPT Cash Flow Chart Period Annual View Absolute Order Latest on the Right Currency United States Dollar (USD) Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec ...